Search

everythinglearnresearchcommunity

for

Search:↓

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

JAK inhibitors may reduce depression in people with alopecia areata.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Upadacitinib effectively treated severe hair loss in a child.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Tick bites can cause hair loss similar to alopecia areata, and baricitinib may help regrow hair.